Generation and preclinical characterization of an antibody specific for SEMA4D
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Semaphorin 4D (SEMA4D or CD100) is a member of the semaphorin family of proteins and an important mediator of the movement and differentiation of multiple cell types, including those of the immune, vascular, and nervous systems. Blocking the binding of SEMA4D to its receptors can result in physiologic changes that may have implications in cancer, autoimmune, and neurological disease. To study the effects of blocking SEMA4D, we generated, in SEMA4D-deficient mice, a panel of SEMA4D-specific hybridomas that react with murine, primate, and human SEMA4D. Utilizing the complementarity-determining regions from one of these hybridomas (mAb 67-2), we generated VX15/2503, a humanized IgG4 monoclonal antibody that is currently in clinical development for the potential treatment of various malignancies and neurodegenerative disorders, including multiple sclerosis and Huntington's disease. This work describes the generation and characterization of VX15/2503, including in vitro functional testing, epitope mapping, and an in vivo demonstration of efficacy in an animal model of rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Semaphorins and their receptors in immune cell interactions
Suzuki, K., Kumanogoh, A., & Kikutani, H. (2008) · Nature Immunology · doi:10.1038/ni1553 · Cited by 400 · cited 1×
“The molecule is expressed on the cell surface as a disulfide-linked homodimer (300-kDa), and upon cell activation the extracellular portion of SEMA4D can be released from the cell surface via proteolytic cleavage to generate a physiologically active, 240-kDa soluble form of the protein (sSEMA4D).(5) SEMA4D is thought…”
BackgroundSemaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II
Takamatsu, H., Takegahara, N., Nakagawa, Y., Tomura, M., Taniguchi, M., Friedel, R. H., Rayburn, H., Tessier-Lavigne, M., Yoshida, Y., Okuno, T., et al. (2010) · Nature Immunology · doi:10.1038/ni.1885 · Cited by 288
Römer, P. S., Berr, S., Avota, E., Na, S.-Y., Battaglia, M., ten Berge, I., Einsele, H., & Hünig, T. (2011) · Blood · doi:10.1182/blood-2010-12-319780 · Cited by 153
Okuno, T., Nakatsuji, Y., Moriya, M., Takamatsu, H., Nojima, S., Takegahara, N., Toyofuku, T., Nakagawa, Y., Kang, S., Friedel, R. H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903302 · Cited by 119
Cited by
Feigin, A., Evans, E. E., Fisher, T. L., Leonard, J. E., Smith, E. S., Reader, A., Mishra, V., Manber, R., Walters, K. A., Kowarski, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01919-8 · Cited by 67
Self-citationTransmembrane semaphorins: Multimodal signaling cues in development and cancer
Gurrapu, S., & Tamagnone, L. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2016.1197479 · Cited by 53
Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity
Evans, E. E., Mishra, V., Mallow, C., Gersz, E. M., Balch, L., Howell, A., Reilly, C., Smith, E. S., Fisher, T. L., & Zauderer, M. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02509-8 · Cited by 44
Self-citation
Metadata
- Authors
- Fisher, T. L., Reilly, C. A., Winter, L. A., Pandina, T., Jonason, A., Scrivens, M., Balch, L., Bussler, H., Torno, S., Seils, J., Mueller, L., Huang, H., Klimatcheva, E., Howell, A., Kirk, R., Evans, E., Paris, M., Leonard, J. E., Smith, E. S., & Zauderer, M.
- Venue
- mAbs
- Publisher
- Informa UK Limited
- Published
- 2015-10-02
- Volume
- 8
- Issue
- 1
- Pages
- 150-162
- ISSN
- 1942-0862 (ISSN-L)
- 1942-0870
- OpenAlex
- W2178772862
- Cited by
- 55
- References
- 5
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Generation and preclinical characterization of an antibody specific for SEMA4D. https://app.cochat.ai/papers/10.1080/19420862.2015.1102813
- The paper
- Fisher, T. L., Reilly, C. A., Winter, L. A., Pandina, T., Jonason, A., Scrivens, M., Balch, L., Bussler, H., Torno, S., Seils, J., Mueller, L., Huang, H., Klimatcheva, E., Howell, A., Kirk, R., Evans, E., Paris, M., Leonard, J. E., Smith, E. S., & Zauderer, M. (2016). Generation and preclinical characterization of an antibody specific for SEMA4D. mAbs. https://doi.org/10.1080/19420862.2015.1102813
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.